5.0
17 Jan 2024
Anonymous employee
Current employee, more than 3 years
Stockholm, Stockholm
Recommend
CEO approval
Business outlook
Pros
A leader in its field - developing medicines to treat Alzheimer's disease, Parkinson's disease and ALS. Great science, great people, great culture!
Cons
Only present in the Nordic countries currently, but growing quickly.